Using targeted and untargeted metabolomic analysis, we discovered that GPS regulated EPA and DHA to improve metabolic disorders through activation of the PPARα pathway, and L-serine and glycine to inhibit inflammation and oxidative stress through suppression of the HIF-1α pathway. Here, HIF1A is linked to metabolic disease.